Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients.

Visani G, Ferrara F, Di Raimondo F, Loscocco F, Sparaventi G, Paolini S, Fuligni F, Gazzola A, Rossi M, Laginestra MA, Caraci MR, Riccardi C, Rocchi M, Visani A, Pileri SA, Piccaluga PP, Isidori A.

Leukemia. 2014 Apr;28(4):967-70. doi: 10.1038/leu.2014.31. Epub 2014 Jan 20. No abstract available.

PMID:
24441289
2.

Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients.

Isidori A, Venditti A, Maurillo L, Buccisano F, Loscocco F, Manduzio P, Sparaventi G, Amadori S, Visani G.

Expert Rev Hematol. 2013 Dec;6(6):767-84. doi: 10.1586/17474086.2013.858018. Review.

PMID:
24219553
3.

An observational study of once weekly intravenous ganciclovir as CMV prophylaxis in heavily pre-treated chronic lymphocytic leukemia patients receiving subcutaneous alemtuzumab.

Visani G, Mele A, Guiducci B, D'Adamo F, Leopardi G, Barulli S, Malerba L, Lucesole M, Sparaventi G, Piccaluga PP, Guernaccini E, Agostinelli F, Isidori A.

Leuk Lymphoma. 2006 Dec;47(12):2542-6.

PMID:
17169798
4.

Consolidation therapy for adult acute myeloid leukemia: a systematic analysis according to evidence based medicine.

Visani G, Olivieri A, Malagola M, Brunori M, Piccaluga PP, Capelli D, Pomponio G, Martinelli G, Isidori A, Sparaventi G, Leoni P.

Leuk Lymphoma. 2006 Jun;47(6):1091-102.

PMID:
16840201
5.

Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.

Mele A, Leopardi G, Sparaventi G, Nicolini G, D'Adamo F, Guiducci B, Barulli S, Malerba L, Stramigioli S, Talevi N, Politi P, Isidori A, Malagola M, Piccaluga P, Visani G.

Eur J Haematol. 2005 Apr;74(4):277-81.

PMID:
15777338
6.

Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.

Visani G, Guiducci B, D'Adamo F, Mele A, Nicolini G, Leopardi G, Sparaventi G, Barulli S, Malerba L, Isidori A, Malagola M, Piccaluga PP.

Leuk Lymphoma. 2005 Mar;46(3):477-9. No abstract available.

PMID:
15621843
7.

No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?

Visani G, Isidori A, Grafone T, Tosi P, Santini V, Malagola M, Martinelli G, Piccaluga PP, Gaziev D, Ottaviani E, Sparaventi G, Tura S.

Leuk Lymphoma. 2004 Jul;45(7):1361-4.

PMID:
15359633
8.

Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas.

Piccaluga PP, Martinelli G, Rondoni M, Malagola M, Gaitani S, Isidori A, Bonini A, Gugliotta L, Luppi M, Morselli M, Sparaventi G, Visani G, Baccarani M.

Leuk Lymphoma. 2004 Sep;45(9):1791-5.

PMID:
15223637
9.

Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.

Mele A, Sparaventi G, Guiducci B, Nicolini G, d'Adamo F, Leopardi G, Delfini C, Piccaluga P, Visani G.

Haematologica. 2004 Jun 1;89(6 Suppl):ECR18. No abstract available.

10.

Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto.

Montillo M, Tedeschi A, Pagano L, Venditti A, Ferrara F, Fabris P, Martino B, Musso M, De Rosa G, Specchia G, Monaco M, Sparaventi G, Spadea A, Palmas A, Deplano W, Manna A, Melillo L, Miraglia E, Mirto S, Mandelli F.

Br J Haematol. 2000 Oct;111(1):334-7.

PMID:
11091221
11.

Haploidentical bone marrow transplantation from mother to child with advanced leukemia.

Polchi P, Lucarelli G, Galimberti M, Giardini C, Baronciani D, Angelucci E, Sparaventi G, Capponi D, Talevi N, Debiagi M, et al.

Bone Marrow Transplant. 1995 Oct;16(4):529-35.

PMID:
8528168
12.

Limiting dilution analysis of IL-2 producing cells: I. Studies of normal human peripheral blood.

Moretti L, Giuliodori L, Stramigioli S, Luchetti F, Baldi A, Sparaventi G.

Haematologica. 1992 Nov-Dec;77(6):463-9.

PMID:
1289183
13.

[An apparently primary lymphoma of the testicle].

Belbusti F, Signoretti P, Tondi MR, Sparaventi G.

G Chir. 1991 Aug-Sep;12(8-9):438-40. Review. Italian.

PMID:
1721520
14.
15.

Purging by dye-mediated photosensitization.

Porcellini A, Manna M, Marchetti-Rossi MT, Sparaventi G.

Bone Marrow Transplant. 1989 Jan;4 Suppl 1:188-9. No abstract available.

PMID:
2653501
16.

[Primary gastric lymphoma. Diagnostic and therapeutic observations on 12 cases].

De Poda D, Beluffi L, Fattori A, Rogheto M, Sparaventi G.

Minerva Chir. 1988 Feb 29;43(4):265-9. Italian. No abstract available.

PMID:
3368093
17.

Malignant melanoma of the glans penis in a chronic myeloid leukemia patient after busulfan therapy.

Sparaventi G, Manna A, Muretto P, Pazzaglia C, Palazzi M, Porcellini A.

Tumori. 1987 Dec 31;73(6):645-8.

PMID:
3481141
18.

Limiting-dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540.

Porcellini A, Talevi N, Marchetti-Rossi MT, Palazzi M, Manna A, Sparaventi G, Delfini C, Valentini M.

Blood. 1987 Nov;70(5):1543-9.

19.

In vitro active cyclophosphamide derivatives in cleansing procedures intended for autologous bone marrow transplantation.

Manna A, Sparaventi G, Palazzi M, Porcellini A.

Haematologica. 1986 May-Jun;71(3):257-61. No abstract available.

PMID:
3093332
20.

[Cryopreservation of bone marrow].

Porcellini A, Manna A, Sparaventi G, Palazzi M.

Riv Emoter Immunoematol. 1985;32(2):143-9. Italian. No abstract available.

PMID:
3911353
21.

Fetal liver transplant in aplastic anemia and acute leukemia.

Izzi T, Polchi P, Galimberti M, Delfini C, Moretti L, Porcellini A, Manna A, Sparaventi G, Giardini C, Angelucci E, et al.

Prog Clin Biol Res. 1985;193:237-49. No abstract available.

PMID:
3911211
22.

Marrow transplantation for thalassemia after treatment with busulfan and cyclophosphamide.

Lucarelli G, Polchi P, Izzi T, Manna M, Delfini C, Galimberti M, Porcellini A, Moretti L, Manna A, Sparaventi G.

Ann N Y Acad Sci. 1985;445:428-31. No abstract available.

PMID:
3893278
23.

Effect of two cyclophosphamide derivatives on hemopoietic progenitor cells and pluripotential stem cells.

Porcellini A, Manna A, Talevi N, Sparaventi G, Marchetti-Rossi MT, Baronciani D, De Biagi M.

Exp Hematol. 1984 Dec;12(11):863-6.

PMID:
6510485

Supplemental Content

Loading ...
Support Center